Vertex Pharmaceuticals Incorporated
Utility Patents
Last updated:
List of all Vertex Pharmaceuticals Incorporated patents 69 in total
| Status | Patent |
|---|---|
Grant | Utility: Modulators of cystic fibrosis transmembrane conductance regulator Filling date: 12 Sep 2025 Issue date: 30 Aug 2022 |
Grant | Utility: Compounds useful as inhibitors of ATR kinase Filling date: 12 Sep 2025 Issue date: 28 Jun 2022 |
Grant | Utility: Methods of preparing inhibitors of influenza viruses replication Filling date: 12 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline- -3-carboxamide Filling date: 12 Sep 2025 Issue date: 5 Apr 2022 |
Grant | Utility: Materials and methods for treatment of hemoglobinopathies Filling date: 12 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Methods of treatment for cystic fibrosis Filling date: 12 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Sulfonamides as modulators of sodium channels Filling date: 12 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator Filling date: 12 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: Pharmaceutical compositions for treating cystic fibrosis Filling date: 12 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Method for treating cancer using a combination of Chk1 and ATR inhibitors Filling date: 12 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Crystalline forms and compositions of CFTR modulators Filling date: 12 Sep 2025 Issue date: 26 Oct 2021 |
Grant | Utility: Pharmaceutical composition and administrations thereof Filling date: 12 Sep 2025 Issue date: 19 Oct 2021 |
Grant | Utility: Methods, compositions and kits for increasing genome editing efficiency Filling date: 12 Sep 2025 Issue date: 21 Sep 2021 |
Grant | Utility: Compounds useful as inhibitors of ATR kinase Filling date: 12 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Compounds useful as inhibitors of ATR kinase and combination therapies thereof Filling date: 12 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors Filling date: 12 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Modulators of ATP-binding cassette transporters Filling date: 12 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators Filling date: 12 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Pteridinone compounds and uses thereof Filling date: 12 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof Filling date: 12 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: DNA-PK inhibitors Filling date: 12 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: DNA-PK inhibitors Filling date: 12 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: GCN2 inhibitors and uses thereof Filling date: 12 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Modulators of ATP-binding cassette transporters Filling date: 12 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases Filling date: 12 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Substituted quinoxaline DNA-PK inhibitors Filling date: 12 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Modulators of ATP-binding cassette transporters Filling date: 12 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Substituted pyrazines as ATR kinase inhibitors Filling date: 12 Sep 2025 Issue date: 30 Mar 2021 |
Grant | Utility: 2,7-dibromospiro[fluorene-9,4'-piperidine] compounds Filling date: 12 Sep 2025 Issue date: 9 Feb 2021 |
Grant | Utility: Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-- fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxa- mide Filling date: 12 Sep 2025 Issue date: 2 Feb 2021 |
Grant | Utility: Inhibitors of influenza viruses replication Filling date: 12 Sep 2025 Issue date: 29 Dec 2020 |
Grant | Utility: Processes for preparing ATR inhibitors Filling date: 12 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: Antiproliferation compounds and uses thereof Filling date: 12 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Compounds useful as inhibitors of ATR kinase Filling date: 12 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Treating cancer with ATR inhibitors Filling date: 12 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto Filling date: 12 Sep 2025 Issue date: 20 Oct 2020 |
Grant | Utility: Compounds useful as inhibitors of ATR kinase Filling date: 12 Sep 2025 Issue date: 13 Oct 2020 |
Grant | Utility: Influenza A virus variants Filling date: 12 Sep 2025 Issue date: 13 Oct 2020 |
Grant | Utility: Influenza A virus variants Filling date: 12 Sep 2025 Issue date: 13 Oct 2020 |
Grant | Utility: GCN2 inhibitors and uses thereof Filling date: 12 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator Filling date: 12 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Prodrugs of pyridone amides useful as modulators of sodium channels Filling date: 12 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: DNA-PK inhibitors Filling date: 12 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Compounds useful as inhibitors of ATR kinase Filling date: 12 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Triazoles for the treatment of demyelinating dieases Filling date: 12 Sep 2025 Issue date: 8 Sep 2020 |
Grant | Utility: Modulators of cystic fibrosis transmembrane conductance regulator Filling date: 12 Sep 2025 Issue date: 1 Sep 2020 |
Grant | Utility: Crystalline forms of C.sub.21H.sub.22Cl.sub.2N.sub.4O.sub.2 Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Pyridone amides as modulators of sodium channels Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Modulators of cystic fibrosis transmembrane conductance regulator Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Materials and methods for treatment of hemoglobinopathies Filling date: 12 Sep 2025 Issue date: 11 Aug 2020 |
Showing 1 to 50 of 69 patents.